Advanced search×

In Memoriam: Robert M. Chanock, MD, 1924–2010.

Albert Z AZ Kapikian, David M DM Morens, and Anthony S AS Fauci

J Infect Dis 203(1):3-5 (2011) PMID 21998882 PMCID PMC3086432

Version: za2963e q8zaa q8zb8 q8zc7 q8zd3 q8zef q8zfa q8zg3
View PDF

Similar articles you may find interesting…

  1. Giant Secondary Grain Growth in Cu Films on Sapphire
    David L Miller, Mark W Keller, and Kyle M Diederichsen

    arXiv:1305.5218 [cond-mat.mtrl-sci] 22 May 2013

    We describe a different approach: sputter deposition at modest Temperatures followed by annealing to induce secondary grain growth. We show That polycrystalline as-deposited Cu on \alpha-Al2O3(0001) can be transformed Into Cu(111) with centimeter-sized grains. Employing optical microscopy, x-ray Dif...
    View PDF
  2. Trends in the medical management of patients with heart failure.
    Samuel W Joffe, Matthew Dewolf, and Robert J Goldberg

    J Clin Med Res 5(3):194-204 (2013) PMID 23671545

    We reviewed the medical records of 9,748 residents of the Worcester, MA, metropolitan area who were hospitalized with ADHF at all 11 central Massachusetts medical centers in 1995, 2000, 2002, and 2004. Between 1995 and 2004, respectively, the prescription upon hospital discharge of b...
    PDF not found
  3. Randomized Selection Design Trial Evaluating CD8+-Enriched Versus Unselected Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy for Pa...
    Mark E Dudley, Colin A Gross, and Steven A Rosenberg

    J Clin Oncol (2013) PMID 23650429

    PURPOSEAdoptive cell therapy (ACT) with autologous tumor-infiltrating lymphocytes (TILs) and high-dose interleukin-2 (IL-2) administered to lymphodepleted patients with melanoma can cause durable tumor regressions. The optimal TIL product for ACT is unknown. PATIENTS AND METHODSPatie...